 |
 |
 |
February 12, 2010 - VIOXX® Ontario court approves Notice of Certification
|
|
 |
|
December 15, 2009 - VIOXX® Ontario court refuses leave to appeal from certification
|
|
|
|
October 22, 2009 - VIOXX® Supreme Court of Canada refuses leave to appeal
|
|
|
|
July 31, 2009 - VIOXX® Ontario Court of Appeal Denies Merck Leave to Appeal; Merck Seeks to Reopen Certification
|
|
|
|
February 20, 2009 - VIOXX® Divisional Court Dismisses Merck's Appeal
|
|
|
|
January 26, 2009 - VIOXX® Merck's Appeal to the Divisional Court
|
|
|
|
July 30, 2008 - VIOXX® Ontario court certifies national class action
|
|
|
|
June 13, 2008 - VIOXX® Certification Hearing in Ontario and Saskatchewan proceedings
|
|
|
|
November 9, 2007 - VIOXX® U.S. Settlement
|
|
|
|
October 2, 2007 - VIOXX® Class Action Certification Hearing Rescheduled
|
|
|
|
June 6, 2007 - VIOXX® Class Action Certification Hearing
|
|
|
|
May 3, 2006 - VIOXX® Amended Fresh Statement of
Claim Filed
|
|
|
|
February 6, 2006 - VIOXX® Press Release
|
|
|
|
February 3, 2006 - Decision on Carriage of VIOXX®
Class Action in Ontario
|
|
|
|
August 22, 2005 - VIOXX® class action update
|
|
|
|
Tough and Podrebarac LLP launches VIOXX® class action
|
|
|
|
|
VIOXX® Class Action Case Evaluation Tough & Podrebarac
LLP has launched a proposed national class action against
Merck & Co., Inc., Merck Frosst Canada Ltd./Merck Frosst Canada
Ltée and Merck Frosst Canada & Co. in relation to the
voluntary recall of VIOXX®, which was announced September
30, 2004.
The lawsuit seeks damages on behalf of the following proposed
class of people:
(a) all persons in Canada who were prescribed
and ingested VIOXX® (rofecoxib) for a period of eighteen
(18) months or more and who have suffered a Cardiovascular
Event, defined as myocardial infarction, unstable angina,
cardiac thrombus, resuscitated cardiac arrest, ischemic
stroke, transient ischemic attacks, cerebrovascular accident,
congestive heart failure, hypertensive crisis, pulmonary
edema, pulmonary embolism and sudden or unexplained death;
and
(b) all persons including, but not limited
to, executors, administrators, personal representatives, spouses
and relatives who on account of a personal relationship to
any one or more of the persons described in (a) above have
a derivative claim for damages resulting from the treatment
with VIOXX®
A copy of the Statement of Claim filed with the Court can
be downloaded by clicking here.
(pdf 581KB)
If you are interested in learning whether you qualify as
a class member please download our VIOXX®
Class Action Case Evaluation Form (pdf 170KB).
You may email the completed form information at vioxxclassaction@toughcounsel.com
or
print this form and fax or mail it to:
TOUGH & PODREBARAC LLP
Suite 300, 166 Pearl Street
Toronto, ON Canada M5H 1L3
Tel: 416.348.7500 - Fax: 416.348.7505
For more information please contact us at the number
provided above.
|
|
